IFNA1 and Hepatic fibrosis: Given that for the IFN-free regimens of chronic hepatitis C treatment the benefits largely exceed the harms, the LS values justifying treatment initiation are lower than those computed on the basis of diagnostic accuracy, independently of the liver fibrosis score.